These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22007275)

  • 41. 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.
    Ekmekcioglu C; Haluza D; Kundi M
    Int J Environ Res Public Health; 2017 Jan; 14(2):. PubMed ID: 28134804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dietary 1,25-dihydroxycholecalciferol has variable effects on the incidences of leg abnormalities, plasma vitamin D metabolites, and vitamin D receptors in chickens divergently selected for tibial dyschondroplasia.
    Mitchell RD; Edwards HM; McDaniel GR; Rowland GN
    Poult Sci; 1997 Feb; 76(2):338-45. PubMed ID: 9057217
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating levels of vitamin D, vitamin D receptor polymorphisms, and colorectal adenoma: a meta-analysis.
    Lee JE
    Nutr Res Pract; 2011 Oct; 5(5):464-70. PubMed ID: 22125685
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vitamin D Status and Cancer Incidence, Survival, and Mortality.
    Kim H; Giovannucci E
    Adv Exp Med Biol; 2020; 1268():39-52. PubMed ID: 32918213
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association between plasma 25-hydroxyvitamin D and colorectal adenoma according to dietary calcium intake and vitamin D receptor polymorphism.
    Yamaji T; Iwasaki M; Sasazuki S; Sakamoto H; Yoshida T; Tsugane S
    Am J Epidemiol; 2012 Feb; 175(3):236-44. PubMed ID: 22193171
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vitamin D, Cancer Risk, and Mortality.
    Tagliabue E; Raimondi S; Gandini S
    Adv Food Nutr Res; 2015; 75():1-52. PubMed ID: 26319903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence.
    Dou R; Ng K; Giovannucci EL; Manson JE; Qian ZR; Ogino S
    Br J Nutr; 2016 May; 115(9):1643-60. PubMed ID: 27245104
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Calcium, vitamin D and cancer.
    Peterlik M; Grant WB; Cross HS
    Anticancer Res; 2009 Sep; 29(9):3687-98. PubMed ID: 19667166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vitamin D
    Grant WB; Moukayed M
    Curr Nutr Rep; 2019 Sep; 8(3):203-211. PubMed ID: 31055734
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of vitamin D and colorectal cancer: casual or causal link?
    Giovannucci E
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):349-54. PubMed ID: 20398758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vitamin D: recent advances.
    DeLuca HF; Schnoes HK
    Annu Rev Biochem; 1983; 52():411-39. PubMed ID: 6311080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of circulating vitamin D binding protein, total, free and bioavailable 25-hydroxy vitamin D in patients with colorectal cancer.
    Yang L; Chen H; Zhao M; Peng P
    Oncotarget; 2017 Jun; 8(25):40214-40221. PubMed ID: 28388568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic Predictors of Circulating 25-Hydroxyvitamin D and Prognosis after Colorectal Cancer.
    Neumeyer S; Butterbach K; Banbury BL; Berndt SI; Campbell PT; Chlebowski RT; Chan AT; Giovannucci EL; Joshi AD; Ogino S; Song M; McCullough ML; Maalmi H; Manson JE; Sakoda LC; Schoen RE; Slattery ML; White E; Win AK; Figueiredo JC; Hopper JL; Macrae FA; Peters U; Brenner H; Hoffmeister M; Newcomb PA; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2020 Jun; 29(6):1128-1134. PubMed ID: 32188599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vitamin D and public health: an overview of recent research on common diseases and mortality in adulthood.
    Scragg R
    Public Health Nutr; 2011 Sep; 14(9):1515-32. PubMed ID: 21729467
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lower serum 25-hydroxyvitamin D is associated with colorectal and breast cancer, but not overall cancer risk: a 20-year cohort study.
    Zhu K; Knuiman M; Divitini M; Hung J; Lim EM; Cooke BR; Walsh JP
    Nutr Res; 2019 Jul; 67():100-107. PubMed ID: 30982554
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
    Wu K; Feskanich D; Fuchs CS; Willett WC; Hollis BW; Giovannucci EL
    J Natl Cancer Inst; 2007 Jul; 99(14):1120-9. PubMed ID: 17623801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vitamin D and vitamin D analogs in cancer treatment.
    van den Bemd GJ; Chang GT
    Curr Drug Targets; 2002 Feb; 3(1):85-94. PubMed ID: 11899952
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
    Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
    J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients.
    Gao Y; Um CY; Fedirko V; Rutherford RE; Seabrook ME; Barry EL; Baron JA; Bostick RM
    PLoS One; 2018; 13(12):e0208762. PubMed ID: 30557404
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: systematic review and meta-analysis of prospective cohort studies.
    Maalmi H; Ordóñez-Mena JM; Schöttker B; Brenner H
    Eur J Cancer; 2014 May; 50(8):1510-21. PubMed ID: 24582912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.